Intervertebral disc degeneration and regenerative medicine

Abstract

Intervertebral disc (IVD) degeneration is a common phenomenon that affects patients with increasing prevalence with increasing age. Both conservative treatments, such as the use of pain medication or physical therapy, and surgical treatments, such as fusion or disc replacement therapies, are offered to patients. Both non-invasive and invasive treatments have been shown to improve pain and quality of life for patients. This review explores the role of regenerative medicine techniques as a promising therapeutic intervention that can be used before or in combination with conservative therapy and surgery to enhance the treatment process in patients with IVD degeneration or disc pathology. Currently, there are four major modules of regenerative medicine: genetic therapy, platelet-rich plasma therapy, stem cell transplantation and tissue engineering. Several research studies have shown promising outcomes of stem cell transplantation and tissue engineering when combined with either surgical or conservative treatment, resulting in improved pain outcomes. The additional benefit of regenerative medicine techniques, specifically stem cell transplantation, is the potential for treating the root pathology of degeneration. Regenerative medicine techniques also have the potential to either halt or reverse degeneration as opposed to current standards of care for managing symptoms. There is a plethora of current research highlighting the benefits of regenerative medicine techniques; however, there remains clinical concerns and ethical concerns regarding the use of regenerative therapy techniques such as stem cell transplantation in the context of IVD degeneration.

Keywords

disc degeneration / intervertebral / intervertebral disc / intervertebral disc (IVD) degeneration surgery / regenerative medicine / stem cells

References

[1] Waxenbaum JA, Reddy V, Futterman B. Anatomy, back, intervertebral discs. StatPearls [Internet]. StatPearls Publishing; 2017.

[2] Dowdell J, Erwin M, Choma T, Vaccaro A, Iatridis J, Cho SK. Intervertebral disc degeneration and repair. Neurosurgery. 2017;80(3S):S46-S54. Erratum in: Neurosurgery. 2018;83(5):1084. PMID: 28350945.

[3] Adams MA, Roughley PJ. What is intervertebral disc degeneration, and what causes it? Spine (Phila Pa 1976). 2006;31(18):2151-2161.

[4] Cheung KMC, Karppinen J, Chan D, et al. Prevalence and pattern of lumbar magnetic resonance imaging changes in a population study of one thousand forty-three individuals. Spine. 2009;34(9):934-940.

[5] Brinjikji W, Diehn FE, Jarvik JG, et al. MRI findings of disc degeneration are more prevalent in adults with low back pain than in asymptomatic controls: a systematic review and meta-analysis. AJNR Am J Neuroradial. 2015;36(12):2394-2399.

[6] Eubanks JD, Lee MJ, Cassinelli E, Ahn NU. Prevalence of lumbar facet arthrosis and its relationship to age, sex, and race: an anatomic study of cadaveric specimens. Spine (Phila Pa 1976). 2007;32(19):2058-2062.

[7] Parenteau CS, Lau EC, Campbell IC, Courtney A. Prevalence of spine degeneration diagnosis by type, age, gender, and obesity using Medicare data. Sci Rep. 2021;11(1):5389.

[8] Schoenfeld AJ, Weiner BK. Treatment of lumbar disc herniation: evidence-based practice. Int J Gen Med. 2010;3:209-214.

[9] Eisenstein SM, Balain B, Roberts S. Current treatment options for intervertebral disc pathologies. Cartilage. 2020;11(2):143-151.

[10] Mobbs RJ, Phan K, Malham G, Seex K, Rao PJ. Lumbar interbody fusion: techniques, indications and comparison of interbody fusion options including PLIF, TLIF, MI-TLIF, OLIF/ATP, LLIF and ALIF. J Spine Surg. 2015;1(1):2-18. PMID: 27683674; PMCID: PMC5039869

[11] Schizas C, Kulik G, Kosmopoulos V. Disc degeneration: current surgical options. Eur Cells Mater. 2010;20:306-315.

[12] Bambakidis NC, Feiz-Erfan I, Klopfenstein JD, Sonntag VK. Indications for surgical fusion of the cervical and lumbar motion segment. Spine. 2005;30(16S):S2-S6.

[13] Mirza SK, Deyo RA. Systematic review of randomized trials comparing lumbar fusion surgery to nonoperative care for treatment of chronic back pain. Spine. 2007;32(7):816-823.

[14] Phillips FM, Slosar PJ, Youssef JA, Andersson G, Papatheofanis F. Lumbar spine fusion for chronic low back pain due to degenerative disc disease: a systematic review. Spine. 2013;38(7):E409-E422.

[15] Buser Z, Ortega B, D'Oro A. Spine degenerative conditions and their treatments: national trends in the United States of America. Global Spine J. 2018;8(1):57-67.

[16] Vital J-M, Boissiere L. Total disc replacement. Orthop Traumatol Surg Res. 2014;100(1):S1-S4.

[17] Hallab N. Intervertebral disc joint replacement technology. Joint Replacement Technology. Woodhead Publishing; 2021:637-674.

[18] Büttner-Janz K, Guyer RD, Ohnmeiss DD, et al. Indications for lumbar total disc replacement: selecting the right patient with the right indication for the right total disc. Int J Spine Surg. 2014;8:12.

[19] Beatty S. We need to talk about lumbar total disc replacement. Int J Spine Surg. 2018;12(2):201-240.

[20] Siepe CJ, Heider F, Wiechert K, Hitzl W, Ishak B, Mayer MH. Mid-to long-term results of total lumbar disc replacement: a prospective analysis with 5-to 10-year follow-up. Spine J. 2014;14(8):1417-1431.

[21] Abi-Hanna D, Kerferd J, Phan K, Rao P, Mobbs R, et al. Lumbar disk arthroplasty for degenerative disk disease: literature review. World Neurosurg. 2018;109:188-196.

[22] Wang D, Xing J, Shao B, et al. A surgical decompression procedure for effective treatment of calcified lumbar disc herniation. J Int Med Res. 2020;48(7):300060520938966.

[23] Yang LH, Liu W, Li J, et al. Lumbar decompression and lumbar interbody fusion in the treatment of lumbar spinal stenosis: a systematic review and meta-analysis. Medicine (Baltimore). 2020;99(27):e20323.

[24] Jain S, Deer T, Sayed D, et al. Minimally invasive lumbar decompression: a review of indications, techniques, efficacy and safety. Pain Manage. 2020;10(5):331-348.

[25] Ahn Y. Endoscopic spine discectomy: indications and outcomes. Int Orthop. 2019;43:909-916.

[26] Bombieri FF, Shafafy R, Elsayed S. Complications associated with lumbar discectomy surgical techniques: a systematic review. J Spine Surg. 2022;8(3):377.

[27] Pannell WC, Savin DD, Scott TP, Wang JC, Daubs MD. Trends in the surgical treatment of lumbar spine disease in the United States. Spine J. 2015;15(8):1719-1727.

[28] Gugliotta M, da Costa BR, Dabis E, et al. Surgical versus conservative treatment for lumbar disc herniation: a prospective cohort study. BMJ Open. 2016;6(12):e012938.

[29] Ma XL, Zhao XW, Ma JX, Li F, Wang Y, Lu B. Effectiveness of surgery versus conservative treatment for lumbar spinal stenosis: a system review and meta-analysis of randomized controlled trials. Int J Surg. 2017;44:329-338. PMID: 28705591.

[30] Sköld C, Tropp H, Berg S. Five-year follow-up of total disc replacement compared to fusion: a randomized controlled trial. Eur Spine J. 2013;22:2288-2295.

[31] Health Quality Ontario. Cervical artificial disc replacement versus fusion for cervical degenerative disc disease: a health technology assessment. Ontario Health Technol Assess Ser. 2019;19(3):1.

[32] Zhang Y, Liang C, Tao Y, et al. Cervical total disc replacement is superior to anterior cervical decompression and fusion: a meta-analysis of prospective randomized controlled trials. PLoS One. 2015;10(3):e0117826.

[33] Masuda K, Lotz JC. New challenges for intervertebral disc treatment using regenerative medicine. Tissue Eng Part B: Rev. 2010;16(1):147-158.

[34] Moran CJ, Barry F, Maher SA, Shannon FJ, Rodeo SA. Advancing regenerative surgery in orthopaedic sports medicine. Am J Sports Med. 2012;40(4):934-944.

[35] Sarkar S, Lin-Gibson S, Allocca CM, Henke D, Getz A. The Critical Role of Standards in Tissue Engineering and Regenerative Medicine. 2018.

[36] Dieckmann C, Renner R, Milkova L, Simon JC. Regenerative medicine in dermatology: biomaterials, tissue engineering, stem cells, gene transfer and beyond. Exp Dermatol. 2010;19(8):697-706.

[37] Yoshida YG, Yan S, Xu H, Yang J. Novel metal nanomaterials to promote angiogenesis in tissue regeneration. Eng Regen. 2023;4(3):265-276.

[38] O'Brien FJ. Biomaterials & scaffolds for tissue engineering. Mater Today. 2011;14(3):88-95.

[39] Echeverria Molina MI, Malollari KG, Komvopoulos K. Design challenges in polymeric scaffolds for tissue engineering. Front Bioeng Biotechnol. 2021;9:617141.

[40] Gonçalves GAR, Paiva RMA. Gene therapy: advances, challenges and perspectives. Einstein (São Paulo). 2017;15(3):369-375.

[41] Everts P, Onishi K, Jayaram P, Lana JF, Mautner K. Platelet-rich plasma: new performance understandings and therapeutic considerations in 2020. Int J Mol Sci. 2020;21(20):7794.

[42] Bongso A, Richards M. History and perspective of stem cell research. Best Pract Res Clin Obstetr Gynaecol. 2004;18(6):827-842.

[43] Kolios G, Moodley Y. Introduction to stem cells and regenerative medicine. Respiration. 2013;85(1):3-10.

[44] Mousaei Ghasroldasht M, Seok J, Park H-S, Liakath Ali FB, Al-Hendy A. Stem cell therapy: from idea to clinical practice. Int J Mol Sci. 2022;23(5):2850.

[45] Zakrzewski W, Dobrzyński M, Szymonowicz M, Rybak Z. Stem cells: past, present, and future. Stem Cell Res Ther. 2019;10(1):68.

[46] Tabansky I, Stern JNH. Basics of stem cell biology as applied to the brain. Stem Cells in Neuroendocrinology. Springer; 2016:11-24.

[47] Liu G, David BT, Trawczynski M, Fessler RG. Advances in pluripotent stem cells: history, mechanisms, technologies, and applications. Stem Cell Rev Rep. 2020;16(1):3-32.

[48] Polykandriotis E, Popescu LM, Horch RE. Regenerative medicine: then and now—an update of recent history into future possibilities. J Cell Mol Med. 2010;14(10):2350-2358.

[49] Yamada K, Iwasaki N, Sudo H. Biomaterials and cell-based regenerative therapies for intervertebral disc degeneration with a focus on biological and biomechanical functional repair: targeting treatments for disc herniation. Cells. 2022;11(4):602.

[50] Sakai D, Andersson GBJ. Stem cell therapy for intervertebral disc regeneration: obstacles and solutions. Nat Rev Rheumatol. 2015;11(4):243-256.

[51] Trounson A, McDonald C. Stem cell therapies in clinical trials: progress and challenges. Cell Stem Cell. 2015;17(1):11-22.

[52] Huang R, Li W, Zhao Y, Yang F, Xu M. Clinical efficacy and safety of stem cell therapy for knee osteoarthritis. Medicine (Baltimore). 2020;99(11):e19434.

[53] Hoang DM, Pham PT, Bach TQ, et al. Stem cell-based therapy for human diseases. Signal Transduct Target Therapy. 2022;7(1):1-41.

[54] Loibl M, Wuertz-Kozak K, Vadala G, Lang S, Fairbank J, Urban JP. Controversies in regenerative medicine: should intervertebral disc degeneration be treated with mesenchymal stem cells? JOR Spine. 2019;2(1):e1043.

[55] Stergar J, Gradisnik L, Velnar T, Maver U. Intervertebral disc tissue engineering: a brief review. Bosn J Basic Med Sci. 2019;19(2):130-137.

[56] Suamte L, Tirkey A, Barman J, Jayasekhar Babu P. Various manufacturing methods and ideal properties of scaffolds for tissue engineering applications. Smart Mater Manuf. 2023;1:100011.

[57] Scharenberg A, Lux C. Therapeutic gene editing safety and specificity. Hematol Oncol Clin North Am. 2017;31(5):787-795.

[58] Gato-Calvo L, Magalhaes J, Ruiz-Romero C, Blanco FJ, Burguera EF. Platelet-rich plasma in osteoarthritis treatment: review of current evidence. Therap Adv Chronic Disease. 2019;10:204062231982556.

[59] Jacques E, Suuronen EJ. The progression of regenerative medicine and its impact on therapy translation. Clin Transl Sci. 2020;13(3):440-450.

[60] Rickert J. On patient safety. Clin Orthop Relat Res. 2019;477(7):1566-1568.

[61] Petrosyan A, Martins PN, Solez K, Uygun BE, Gorantla VS, Orlando G. Regenerative medicine applications: an overview of clinical trials. Front Bioeng Biotechnol. 2022;10:942750.

[62] Jessop ZM, Al-Sabah A, Francis WR, Whitaker IS. Transforming healthcare through regenerative medicine. BMC Med. 2016;14(1):115.

[63] Mochida J, Sakai D, Nakamura Y, Watanabe T, Yamamoto Y, Kato S. Intervertebral disc repair with activated nucleus pulposus cell transplantation: a three-year, prospective clinical study of its safety. Eur Cells Mater. 2015;29:202-212.

[64] Yoshikawa T, Ueda Y, Miyazaki K, Koizumi M, Takakura Y. Disc regeneration therapy using marrow mesenchymal cell transplantation. Spine. 2010;35(11):E475-E480.

[65] Orozco L, Soler R, Morera C, Alberca M, Sánchez A, García-Sancho J. Intervertebral disc repair by autologous mesenchymal bone marrow cells: a pilot study. Transplantation. 2011;92(7):822-828.

[66] Gomez-Ruiz V, Blanco JF, Villarón E, Fidalgo H, López-Parra M, Sánchez-Guijo F. Autologous mesenchymal stem cell transplantation for spinal fusion: 10 years follow-up of a phase I/II clinical trial. Stem Cell Res Ther. 2023;14(1):78.

[67] Auiero D, Vincent H, Sampson S, Bodor M. Regenerative injection treatment in the spine: review and case series with platelet rich plasma. J Stem Cells Res Rev Rep. 2015;2(1):1019.

[68] Vieira W, McCusker C. Regenerative models for the integration and regeneration of head skeletal tissues. Int J Mol Sci. 2018;19(12):3752.

[69] Wu C, Chin CSM, Huang Q, et al. Rapid nanomolding of nanotopography on flexible substrates to control muscle cell growth with enhanced maturation. Microsyst Nanoeng. 2021;7(1):89.

[70] Lim JY, Loiselle AE, Lee JS, Zhang Y, Salvi JD, Donahue HJ. Optimizing the osteogenic potential of adult stem cells for skeletal regeneration. J Orthop Res. 2011;29(11):1627-1633.

[71] Wang D-A, Varghese S, Sharma B, et al. Multifunctional chondroitin sulphate for cartilage tissue–biomaterial integration. Nat Mater. 2007;6(5):385-392.

[72] World Health Organization. Low Back Pain. 2023, June 19.

[73] Soufi KH, Castillo JA, Rogdriguez FY, DeMesa CJ, Ebinu JO. Potential role for stem cell regenerative therapy as a treatment for degenerative disc disease and low back pain: a systematic review. Int J Mol Sci. 2023;24(10):8893.

[74] Foster NE, Anema JR, Cherkin D, et al. Prevention and treatment of low back pain: evidence, challenges, and promising directions. Lancet. 2018;391(10137):2368-2383.

[75] Ibrahim T, Tleyjeh IM, Gabbar O. Surgical versus non-surgical treatment of chronic low back pain: a meta-analysis of randomised trials [published correction appears in Int Orthop. 2009;33(2):589-590]. Int Orthop. 2008;32(1):107-113.

[76] Marfia G, Campanella R, Navone SE, et al. Potential use of human adipose mesenchymal stromal cells for intervertebral disc regeneration: a preliminary study on biglycan-deficient murine model of chronic disc degeneration. Arthritis Res Ther. 2014;16(5):457.

[77] Silverman LI, Dulatova G, Tandeski T, et al. In vitro and in vivo evaluation of discogenic cells, an investigational cell therapy for disc degeneration. Spine J. 2020;20(1):138-149.

[78] Murphy MB, Moncivais K, Caplan AI. Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine. Exp Mol Med. 2013;45(11):e54.

[79] Volkova N, Yukhta M, Goltsev A. Cryopreserved mesenchymal stem cells stimulate regeneration in an intervertebral disc. Biomedicines. 2015;3(3):237-247.

[80] Vadalà G, Russo F, Ambrosio L, Loppini M, Denaro V. Stem cells sources for intervertebral disc regeneration. World J Stem Cells. 2016;8(5):185-201.

[81] Vadalà G, Sowa GA, Kang JD. Gene therapy for disc degeneration. Expert Opin Biol Ther. 2007;7(2):185-196.

[82] Sivakamasundari V, Lufkin T. Stemming the degeneration: IVD stem cells and stem cell regenerative therapy for degenerative disc disease. Adv Stem Cells. 2013;2013:724547.

[83] Li Q, Wang D, Jiang Z, et al. Advances of hydrogel combined with stem cells in promoting chronic wound healing. Front Chem. 2022;10:1038839.

[84] Chen WH, Liu HY, Lo WC, et al. Intervertebral disc regeneration in an ex vivo culture system using mesenchymal stem cells and platelet-rich plasma. Biomaterials. 2009;30(29):5523-5533.

[85] Hu B, He R, Ma K, et al. Intervertebral disc-derived stem/progenitor cells as a promising cell source for intervertebral disc regeneration. Stem Cells Int. 2018;2018:7412304.

[86] Sakai D, Nakamura Y, Nakai T, et al. Exhaustion of nucleus pulposus progenitor cells with ageing and degeneration of the intervertebral disc. Nat Commun. 2012;3:1264.

[87] Gradišnik L, Maver U, Gole B, et al. The endplate role in degenerative disc disease research: the isolation of human chondrocytes from vertebral endplate—an optimised protocol. Bioengineering (Basel). 2022;9(4):137.

[88] Tomaszewski KA, Saganiak K, Gładysz T, Walocha JA. The biology behind the human intervertebral disc and its endplates. Folia Morphol (Warsz). 2015;74(2):157-168.

[89] Zhang W, Sun T, Li Y, et al. Application of stem cells in the repair of intervertebral disc degeneration. Stem Cell Res Ther. 2022;13(1):70.

[90] Wei A, Shen B, Williams L, Diwan A. Mesenchymal stem cells: potential application in intervertebral disc regeneration. Transl Pediatr. 2014;3(2):71-90.

[91] Stoyanov JV, Gantenbein-Ritter B, Bertolo A, et al. Role of hypoxia and growth and differentiation factor-5 on differentiation of human mesenchymal stem cells towards intervertebral nucleus pulposus-like cells. Eur Cell Mater. 2011;21:533-547.

[92] Risbud MV, Albert TJ, Guttapalli A, et al. Differentiation of mesenchymal stem cells towards a nucleus pulposus-like phenotype in vitro: implications for cell-based transplantation therapy. Spine (Phila Pa 1976). 2004;29(23):2627-2632.

[93] Acosta FL, Lotz J, Ames CP. The potential role of mesenchymal stem cell therapy for intervertebral disc degeneration: a critical overview. Neurosurg Focus. 2005;19(3):E4.

[94] Gou S, Oxentenko SC, Eldrige JS, et al. Stem cell therapy for intervertebral disk regeneration. Am J Phys Med Rehabil. 2014;93(11):S122-S131.

[95] Wang Z, Perez-Terzic CM, Smith J, et al. Efficacy of intervertebral disc regeneration with stem cells—a systematic review and meta-analysis of animal controlled trials. Gene. 2015;564(1):1-8.

[96] Sakai D, Mochida J, Iwashina T, et al. Regenerative effects of transplanting mesenchymal stem cells embedded in atelocollagen to the degenerated intervertebral disc. Biomaterials. 2006;27(3):335-345.

[97] Abbassy AA, Trebinjac S, Kotb N. The use of cellular matrix in symptomatic knee osteoarthritis. Bosn J Basic Med Sci. 2020;20(2):271-274.

[98] Filardo G, Kon E, Di Martino A, et al. Platelet-rich plasma vs hyaluronic acid to treat knee degenerative pathology: study design and preliminary results of a randomized controlled trial. BMC Musculoskelet Disord. 2012;13:229.

[99] Volarevic V, Markovic BS, Gazdic M, et al. Ethical and safety issues of stem cell-based therapy. Int J Med Sci. 2018;15(1):36-45.

[100] Barakat AH, Elwell VA, Lam KS. Stem cell therapy in discogenic back pain. J Spine Surg. 2019;5(4):561-583.

[101] Rothoerl R, Tomelden J, Alt EU. Safety and efficacy of autologous stem cell treatment for facetogenic chronic back pain. J Pers Med. 2023;13(3):436.

[102] Sharan J, Barmada A, Prodromos C, Candido K. First human report of relief of lumbar and cervical discogenic and arthritic back pain after epidural and facet joint mesenchymal stem cell injection: a case report. Curr Stem Cell Res Ther. 2023;18(7):1013-1015.

[103] Zhang J, Zhang J, Zhang Y, et al. Mesenchymal stem cells-derived exosomes ameliorate intervertebral disc degeneration through inhibiting pyroptosis. J Cell Mol Med. 2020;24(20):11742-11754.

[104] Liu MH, Bian BS, Cui X, et al. Mesenchymal stem cells regulate mechanical properties of human degenerated nucleus pulposus cells through SDF-1/CXCR4/AKT axis. Biochim Biophys Acta. 2016;1863(8):1961-1968.

[105] Motejunas MW, Bonneval L, Carter C, Reed D, Ehrhardt K. Biologic therapy in chronic pain management: a review of the clinical data and future investigations. Curr Pain Headache Rep. 2021;25(5):30.

[106] Lo B, Parham L. Ethical issues in stem cell research. Endocr Rev. 2009;30(3):204-213.

[107] Long F. Building strong bones: molecular regulation of the osteoblast lineage. Nat Rev Mol Cell Biol. 2011;13(1):27-38.

[108] ElHawary H, Baradaran A, Abi-Rafeh J, Vorstenbosch J, Xu L, Efanov JI. Bone healing and inflammation: principles of fracture and repair. Semin Plast Surg. 2021;35(3):198-203.

[109] Sheen JR, Mabrouk A, Garla VV. Fracture healing overview. StatPearls [Internet]. StatPearls Publishing; 2023 [updated 2023 Apr 8].

[110] Salhotra A, Shah HN, Levi B, Longaker MT. Mechanisms of bone development and repair. Nat Rev Mol Cell Biol. 2020;21(11):696-711.

[111] Steck E, Bertram H, Abel R, Chen B, Winter A, Richter W. Induction of intervertebral disc-like cells from adult mesenchymal stem cells. Stem Cells. 2005;23(3):403-411.

[112] Chen WH, Lo WC, Lee JJ, et al. Tissue-engineered intervertebral disc and chondrogenesis using human nucleus pulposus regulated through TGF-beta1 in platelet-rich plasma. J Cell Physiol. 2006;209(3):744-754.

[113] Tsuchiya H, Kitoh H, Sugiura F, Ishiguro N. Chondrogenesis enhanced by overexpression of sox9 gene in mouse bone marrow-derived mesenchymal stem cells. Biochem Biophys Res Commun. 2003;301(2):338-343.

[114] Babister JC, Tare RS, Green DW, Inglis S, Mann S, Oreffo RO. Genetic manipulation of human mesenchymal progenitors to promote chondrogenesis using “bead-in-bead” polysaccharide capsules. Biomaterials. 2008;29(1):58-65.

[115] Yoshikawa T, Ueda Y, Miyazaki K, Koizumi M, Takakura Y. Disc regeneration therapy using marrow mesenchymal cell transplantation: a report of two case studies. Spine (Phila Pa 1976). 2010;35(11):E475-E480.

[116] Binato R, de Souza Fernandez T, Lazzarotto-Silva C, et al. Stability of human mesenchymal stem cells during in vitro culture: considerations for cell therapy. Cell Prolif. 2013;46(1):10-22.

[117] Bernardo ME, Zaffaroni N, Novara F, et al. Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res. 2007;67(19):9142-9149.

[118] Schellenberg A, Stiehl T, Horn P, et al. Population dynamics of mesenchymal stromal cells during culture expansion. Cytotherapy. 2012;14(4):401-411.

[119] Zhang F, Wang S, Li B, Tian W, Zhou Z, Liu S. Intradiscal injection for the management of low back pain. JOR Spine. 2021;5(1):e1186.

[120] Basso M, Cavagnaro L, Zanirato A, et al. What is the clinical evidence on regenerative medicine in intervertebral disc degeneration? Musculoskelet Surg. 2017;101(2):93-104.

[121] Knezevic NN, Mandalia S, Raasch J, Knezevic I, Candido KD. Treatment of chronic low back pain—new approaches on the horizon. J Pain Res. 2017;10:1111-1123.

[122] Van SP. 7 Ways to Treat Chronic Back Pain Without Surgery. June 9, 2022. Accessed December 3, 2023.

[123] Ringwalt C, Gugelmann H, Garrettson M, et al. Differential prescribing of opioid analgesics according to physician specialty for Medicaid patients with chronic noncancer pain diagnoses. Pain Res Manag. 2014;19:179-185.

[124] Nguyen TH, Randolph DC, Talmage J, zhan Succop P, Travis R. Long-term outcomes of lumbar fusion among workers' compensation subjects: a historical cohort study. Spine (Phila Pa 1976). 2011;36(4):320-331.

[125] Mayer JE, Iatridis JC, Chan D, Qureshi SA, Gottesman O, Hecht AC. Review: genetic polymorphisms associated with intervertebral disc degeneration. Spine J. 2013;13(3):299-317.

[126] Sakai D, Andersson GBJ. Stem cell therapy for intervertebral disc regeneration: obstacles and solutions. Nat Rev Rheumatol. 2015;11(4):243-256.

[127] Feng G, Yang X, Shang H, et al. Multipotential differentiation of human anulus fibrosus cells: an in vitro study. J Bone Joint Surg Am. 2010;92(3):675-685.

[128] Piccirilli M, Delfinis CP, Santoro A, Salvati M. Mesenchymal stem cells in lumbar spine surgery: a single institution experience about red bone marrow and fat tissue derived MSCs. J Neurosurg Sci. 2017;61(2):124-133.

[129] Kumar H, Ha DH, Lee EJ, et al. Safety and tolerability of intradiscal implantation of combined autologous adipose-derived mesenchymal stem cells and hyaluronic acid in patients with chronic discogenic low back pain: 1-year follow-up of a phase I study. Stem Cell Res Ther. 2017;8(1):262.

[130] Roberts S, Evans EH, Kletsas D, Jaffray DC, Eisenstein SM. Senescence in human intervertebral discs. Eur Spine J. 2006;15(3):312-316.

[131] Pattappa G, Peroglio M, Sakai D, et al. CCL5/RANTES is a key chemoattractant released by degenerative intervertebral discs in organ culture. Eur Cell Mater. 2014;27:124-136. Discussion 136.

[132] Illien-Jünger S, Pattappa G, Peroglio M, et al. Homing of mesenchymal stem cells in induced degenerative intervertebral discs in a whole organ culture system. Spine. 2012;37(22):1865.

[133] Pettine KA, Murphy MB, Suzuki RK, Sand TT. Percutaneous injection of autologous bone marrow concentrate cells significantly reduces lumbar discogenic pain through 12 months. Stem Cells. 2015;33(1):146-156.

[134] Reid PC, Morr S, Kaiser MG. State of the union: a review of lumbar fusion indications and techniques for degenerative spine disease: JNSPG 75th Anniversary Invited Review Article. J Neurosurg Spine. 2019;31(1):1-14.

[135] Mochida J, Sakai D, Nakamura Y, Watanabe T, Yamamoto Y, Kato S. Intervertebral disc repair with activated nucleus pulposus cell transplantation: a three-year, prospective clinical study of its safety. Eur Cell Mater. 2015;29:202-212. Discussion 212.

[136] Sakai D, Schol J, Watanabe M. Clinical development of regenerative medicine targeted for intervertebral disc disease. Medicina (Mex). 2022;58(2):267.

[137] Schneider BJ, Hunt C, Conger A, et al. The effectiveness of intradiscal biologic treatments for discogenic low back pain: a systematic review. Spine J. 2022;22(2):226-237.

[138] Cheng J, Santiago KA, Nguyen JT, Solomon JL, Lutz GE. Treatment of symptomatic degenerative intervertebral discs with autologous platelet-rich plasma: follow-up at 5–9 years. Regen Med. 2019;14(9):831-840.

[139] Navani A, Hames A. Platelet-rich plasma injections for lumbar discogenic pain: a preliminary assessment of structural and functional changes. Techn Regional Anesth Pain Manage. 2015;19(1):38-44.

[140] Jarrah RM, Potes MDA, Vitija X, et al. Alginate hydrogels: a potential tissue engineering intervention for intervertebral disc degeneration. J Clin Neurosci. 2023;113:32-37.

[141] Song C, Xu Y, Peng Q, et al. Mitochondrial dysfunction: a new molecular mechanism of intervertebral disc degeneration. Inflamm Res. 2023;72(12):2249-2260.

[142] Jia Z, Zhang S, Li W. Harnessing stem cell-derived extracellular vesicles for the regeneration of degenerative bone conditions. Int J Nanomed. 2023;18:5561-5578.

[143] Aslankoohi N, Mondal D, Rizkalla AS, Mequanint K. Bone repair and regenerative biomaterials: towards recapitulating the microenvironment. Polymers (Basel). 2019;11(9):1437.

[144] Bhatia SK. Biomaterials for Clinical Applications. Springer; 2010.

[145] Hu C. Ions-induced gelation of alginate: mechanisms and applications. Int J Biol Macromol. 2021;177:578-588.

[146] Möller L, Krause A, Dahlmann J, Gruh I, Kirschning A, Dräger G. Preparation and evaluation of hydrogel-composites from methacrylated hyaluronic acid, alginate, and gelatin for tissue engineering. Int J Artif Organs. 2011;34(2):93-102.

[147] Tavafoghi M, Sheikhi A, Tutar R, et al. Engineering tough, injectable, naturally derived, bioadhesive composite hydrogels. Adv Healthc Mater. 2020;9(10):1901722.

[148] Shirazi-Adl A, El-Rich M, Pop DG, Parnianpour M. Spinal muscle forces, internal loads and stability in standing under various postures and loads—application of kinematics-based algorithm. Eur Spine J. 2005;14(4):381-392.

[149] Neves MI, Moroni L, Barrias CC. Modulating alginate hydrogels for improved biological performance as cellular 3D microenvironments. Front Bioeng Biotechnol. 2020;8:665.

[150] Abasalizadeh F, Moghaddam SV, Alizadeh E, et al. Alginate-based hydrogels as drug delivery vehicles in cancer treatment and their applications in wound dressing and 3D bioprinting. J Biol Eng. 2020;14(1):8.

[151] Leone G, Torricelli P, Chiumiento A, Facchini A, Barbucci R. Amidic alginate hydrogel for nucleus pulposus replacement. J Biomed Mater Res Part A. 2008;84A(2):391-401.

[152] Ura K, Yamada K, Tsujimoto T, Ukeba D, Iwasaki N, Sudo H. Ultra-purified alginate gel implantation decreases inflammatory cytokine levels, prevents intervertebral disc degeneration, and reduces acute pain after discectomy. Sci Rep. 2021;11(1):638.

[153] Tsujimoto T, Sudo H, Todoh M, et al. An acellular bioresorbable ultra-purified alginate gel promotes intervertebral disc repair: a preclinical proof-of-concept study. EBioMedicine. 2018;37:521-534.

[154] Zeng Z, Zhou X, Wang Y, et al. Mitophagy—a new target of bone disease. Biomolecules. 2022;12(10):1420.

[155] Francisco V, Pino J, González-Gay MÁ, et al. A new immunometabolic perspective of intervertebral disc degeneration. Nat Rev Rheumatol. 2022;18(1):47-60.

[156] Wang F, Cai F, Shi R, Wang XH, Wu XT. Aging and age related stresses: a senescence mechanism of intervertebral disc degeneration. Osteoarthritis Cartil. 2016;24(3):398-408.

[157] Strassburg S, Hodson NW, Hill PI, Richardson SM, Hoyland JA. Bi-directional exchange of membrane components occurs during co-culture of mesenchymal stem cells and nucleus pulposus cells. PLoS One. 2012;7(3):e33739.

[158] Weng Z, Zhang B, Wu C, et al. Therapeutic roles of mesenchymal stem cell-derived extracellular vesicles in cancer. J Hematol Oncol. 2021;14(1):136.

[159] Cappariello A, Loftus A, Muraca M, Maurizi A, Rucci N, Teti A. Osteoblast-derived extracellular vesicles are biological tools for the delivery of active molecules to bone. J Bone Miner Res. 2018;33(3):517-533.

[160] Zhdanov VP. Ligand-receptor-mediated attachment of lipid vesicles to a supported lipid bilayer. Eur Biophys J. 2020;49(5):395-400.

[161] Lin Z, Xiong Y, Meng W, et al. Exosomal PD-L1 induces osteogenic differentiation and promotes fracture healing by acting as an immunosuppressant. Bioact Mater. 2022;13:300-311.

[162] Bhujel B, Shin HE, Choi DJ, Han I. Mesenchymal stem cell-derived exosomes and intervertebral disc regeneration: review. Int J Mol Sci. 2022;23(13):7306.

[163] Zhu G, Yang X, Peng C, Yu L, Hao Y. Exosomal miR-532-5p from bone marrow mesenchymal stem cells reduce intervertebral disc degeneration by targeting RASSF5. Exp Cell Res. 2020;393(2):112109.

[164] Yuan Q, Wang X, Liu L, et al. Exosomes derived from human placental mesenchymal stromal cells carrying AntagomiR-4450 alleviate intervertebral disc degeneration through upregulation of ZNF121. Stem Cells Dev. 2020;29(16):1038-1058.

[165] Hu Q, Lyon CJ, Fletcher JK, Tang W, Wan M, Hu TY. Extracellular vesicle activities regulating macrophage-and tissue-mediated injury and repair responses. Acta Pharm Sin B. 2021;11(6):1493-1512.

[166] Koroth J, Buko EO, Abbott R, et al. Macrophages and intervertebral disc degeneration. Int J Mol Sci. 2023;24(2):1367.

[167] Sun Y, Zhang W, Li X. Induced pluripotent stem cell-derived mesenchymal stem cells deliver exogenous miR-105-5p via small extracellular vesicles to rejuvenate senescent nucleus pulposus cells and attenuate intervertebral disc degeneration. Stem Cell Res Ther. 2021;12(1):286.

RIGHTS & PERMISSIONS

2024 The Authors. Clinical and Translational Discovery published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.